 ?您的位置：對照品 > 試劑耗材 > 生化試劑 > |
|
|
|
| 產品基本信息 |
|
| 產品編號：124691 |
| 產品名稱：阿戈美拉汀, ≥98%(HPLC) |
| 產品CAS：138112-76-2 |
| 規格含量：5mg |
| 產品價格：980 |
| 聯系我們: |
 |
|
 |
|
|
| 產品詳細介紹 |
阿戈美拉汀, ≥98%(HPLC)
Product Name： Agomelatine
CAS號:138112-76-2
分子式:C15H17NO2
分子量:243.30
介紹： Agomelatine is an extremely potent agonist at both melatonin receptors (MT1 and MT2), with additional antagonism at 5HT2C. It is a novel antidepressant with many desired in vivo properties, including neuroprotection and neurogenesis in depression-sensitive brain areas. Agomelatine′s efficacy appears to be due to both melatonergic and serotonergic properties. In neurogenesis assays, both in vitro and in vivo, the compound effects were differentially affected by antagonists for MT1/MT2 and 5HT2C, demonstrating actions through all three receptors.
貯存： 儲存溫度 2-8°C
生化和生理學機理：
Agomelatine is a competitive antagonist of human and porcine serotonin (5-HT2C) receptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6). It is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Activation of 5-HT2C receptors by serotonin inhibits dopamine and norepinephrine release. Antagonism of 5-HT2C results in an enhancement of DA and NE release and activity of frontocortical dopaminergic and adrenergic pathways. Agomelatine is also a potent agonist at melatonin receptors which makes it the first melatonergic antidepressant. Agomelatine is an antidepressant drug.
|
|
|
|
|
